Evidence map›Paper›PMID 36394823›Full record

ArticleDrugs - real world outcomes2023

Promise of Real-World Evidence for Patient Centricity in Gulf Cooperation Council Countries: Call to Action.

Mohamed Nasr Mahmoud Hassan Farghaly, Ibrahim Sulaiman Mas'oud Al Ghaithi, Wael Abdel Rahman Mahamid, Abdallah Adlan, Saleh Mohammed AlGhamdi, Thamir M Al Shammari, Nasser Mohammed Alqahtani, Suliman A Al Ghnam, Marie Sleiman Awad Ibrahim, Hajer Al Mudaiheem and 6 more

Abstract read
In one paragraph

Article in Drugs - real world outcomes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Mohamed Nasr Mahmoud Hassan FarghalyDubai Medical College, Dubai, United Arab Emirates.
Ibrahim Sulaiman Mas'oud Al GhaithiConsultant, Pediatric Hematology/Oncology, Royal Hospital, Muskat, Oman.
Wael Abdel Rahman MahamidHeart and Vascular Institute Cleveland Clinic, Abu Dhabi, United Arab Emirates.
Abdallah AdlanBioethics Saudi National Institute of Health Research Forum, Riyadh, Saudi Arabia.
Saleh Mohammed AlGhamdiApplied Clinical Research, King Fahad Medical City, Riyadh, Saudi Arabia.
Thamir M Al ShammariCollege of Pharmacy, Riyadh Elm University, Riyadh, Saudi Arabia.
Nasser Mohammed AlqahtaniEvidence Based Medicine Committee, Riyadh, Saudi Arabia.
Suliman A Al GhnamKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Marie Sleiman Awad IbrahimInsights Research Organization & Solutions (IROS), Abu Dhabi, United Arab Emirates.
Hajer Al MudaiheemMinistry of Health, Riyadh, Saudi Arabia.
Mohamed Zahir ChouikratSanofi, Dubai, United Arab Emirates.
Yahia AkthamSanofi, Jeddah, Kingdom of Saudi Arabia.
Marwan Essam El BagourySanofi, Dubai, United Arab Emirates.
Arun Jayarame GowdaPrincipal, Management Consulting, AMESA, IQVIA, Bangalore, India. ajayaramegowda@in.imshealth.com.
Khalid Al MoaikelRWE Kingdom of Saudi Arabia, IQVIA, Riyadh, Saudi Arabia.
Nancy Syed Awad AbdallahDirector, Commercial Offerings, ME, IQVIA, Dubai, United Arab Emirates.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Presently, Gulf Cooperation Council countries are lagging in the generation of real-world data and use of real-world evidence for patient-centered care compared with the global average. In a collaborative effort, experts from multiple domains of the healthcare environment from the Gulf Cooperation Council countries came together to present their views and recommended key action points for the generation of robust real-world data and leveraging real-world evidence in the countries. The opinions of the experts are presented, along with existing barriers to the effective generation of real-world evidence in the countries. The Gulf Cooperation Council countries are undergoing transformative changes paving the way for improved healthcare measures; however, the challenges in generating reliable, robust, accessible, and secure real-world evidence are persistent. Hence, ongoing public-private engagements, as well as collaborations between regulators, policymakers, healthcare professionals, insurance and pharmaceutical companies, and patients, are warranted. A few notable examples of real-world evidence studies highlighting the benefits of real-world evidence for gaining valuable insights into patient-centric decision making are also discussed. The actionable steps identified for successful real-world evidence generation would provide long-term, real-world evidence-based patient-centric benefits for the countries.

Identifiers

PMID36394823
PMCPMC9944129

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.